These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2454343)

  • 1. [Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
    Abdalla A; Mazur NA
    Kardiologiia; 1988 Mar; 28(3):51-4. PubMed ID: 2454343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the effectiveness of allapinin in patients with frequent and stable extrasystole].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Kardiologiia; 1988 Nov; 28(11):95-7. PubMed ID: 2466144
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of combinations of group I anti-arrhythmia drugs in patients with refractory arrhythmias].
    Abdalla A; Mazur NA; Ivanova LA; Sumarokov AV
    Kardiologiia; 1988 Feb; 28(2):42-6. PubMed ID: 2453699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of allapinin after a single intravenous administration to patients with chronic ventricular extrasystole].
    Sokolov SF; Alikhanov GN; Golitsyn SP; Dzhakhangirov FN; Smetnev AS
    Kardiologiia; 1988 Feb; 28(2):46-52. PubMed ID: 2453700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of an anti-arrhythmia drug mexicord in the treatment of ventricular extrasystole].
    Urumbaev RK; Suprunova IP; Imanakunova DSh; Rakhimova GR
    Kardiologiia; 1992 Mar; 32(3):48-50. PubMed ID: 1383590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and pharmacodynamics of the new Russian anti-arrhythmia drug allapinin].
    Abdalla A; Rulin VA; Mazur NA; Sumarokov AB; Chikovani SI
    Kardiologiia; 1989 Jan; 29(1):32-6. PubMed ID: 2471868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
    Smetnev AS; Ponomarenko EL; Koltunova MI; Shugushev KhKh
    Kardiologiia; 1987 May; 27(5):24-6. PubMed ID: 2443743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmic effectiveness of allapinin in ventricular arrhythmia in patients with circulatory failure].
    Naumov VG; Blinov SI; Khodzhakuliev BG; Vangeli RS
    Ter Arkh; 1988; 60(8):39-41. PubMed ID: 2465582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
    Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
    Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of ethacizin in ventricular arrhythmias refractory to prior anti-arrhythmia drug therapy].
    Shugushev KhKh
    Kardiologiia; 1986 Jun; 26(6):43-7. PubMed ID: 2429007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of long-term therapy with a combination of various anti-arrhythmia agents].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Klin Med (Mosk); 1989 Mar; 67(3):79-82. PubMed ID: 2473246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effectiveness of cordarone in combination with other anti-arrhythmia agents in refractory atrial fibrillation and adverse effects of the drugs].
    Denisiuk VI; Lipnitskiĭ TN; Kotsuta GI; Pilipchuk VP; Stepaniuk AV; Osiadlaia ES
    Kardiologiia; 1992 Jun; 32(6):39-42. PubMed ID: 1405291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in the clinical use of etmozin in different cardiac rhythm disturbances].
    Mazur NA; Liakishev AA; Kubanov RD
    Kardiologiia; 1980 Jul; 20(7):44-9. PubMed ID: 6157047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
    Abdalla A; Mazur NA; Nazarenko VA
    Kardiologiia; 1991 Jun; 31(6):22-5. PubMed ID: 1717733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in long-term use of allapinin in polyclinical practice].
    Gasilin VS; Dorofeeva EV; Rozova NK; Piskareva IN; Chernysheva GV
    Kardiologiia; 1990 Sep; 30(9):30-2. PubMed ID: 1703254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of prolonged ethmozine treatment in patients with ventricular arrhythmias].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1983 Nov; 23(11):51-5. PubMed ID: 6197557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.